Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

ClinicalTrials.gov ID: NCT06747858

Public ClinicalTrials.gov record NCT06747858. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 10, 2026, 9:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-label, Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Efficacy of ARCT-032 in People With Cystic Fibrosis

Study identification

NCT ID: NCT06747858
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Arcturus Therapeutics, Inc.; Industry
Enrollment: 33 participants

Conditions and interventions

Conditions

Interventions

ARCT-032 Biological

Biological

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 11, 2024
Primary completion: May 31, 2027
Completion: May 31, 2027
Last update posted: May 7, 2026

2024 – 2027

United States locations

U.S. sites: 13
U.S. states: 13
U.S. cities: 13

Facility	City	State	ZIP	Site status
University of Arizona	Tucson	Arizona	85724	Recruiting
University of Arkansas for Medical Sciences	Little Rock	Arkansas	72205	Recruiting
Children's Hospital of Los Angeles	Los Angeles	California	90027	Recruiting
Children's National Hospital	Washington D.C.	District of Columbia	20010	Not yet recruiting
Joe DiMaggio Children's Hospital	Hollywood	Florida	33021	Recruiting
The Cystic Fibrosis Institute	Northfield	Illinois	60093	Active, not recruiting
Boston Children's Hospital	Boston	Massachusetts	02115	Recruiting
Washington University School of Medicine	St Louis	Missouri	63144	Recruiting
Cleveland Clinic Foundation	Cleveland	Ohio	44195	Recruiting
Medical University of South Carolina	Charleston	South Carolina	29425	Recruiting
Vanderbilt University Medical Center	Nashville	Tennessee	37232	Recruiting
UT Health San Antonio	San Antonio	Texas	78229	Recruiting
Seattle Children's Hospital	Seattle	Washington	98105	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06747858, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 7, 2026 · Synced May 10, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06747858 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →